市场调查报告书
商品编码
1468031
羊膜产品市场:按类型、应用和最终用户划分 - 全球预测 2024-2030Amniotic Products Market by Type (Amniotic Membranes, Amniotic Suspensions), Application (Ophthalmology, Orthopedics, Wound Care), End-User - Global Forecast 2024-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
预计2023年羊膜产品市场规模为10.6亿美元,预计2024年将达到11.6亿美元,2030年将达到20.8亿美元,复合年增长率为10.12%。
羊膜产品是一类再生医学疗法,源自于健康足月妊娠后人类捐赠者的胎盘和羊膜的羊膜组织。这些产品可用于各种医疗应用,包括组织再生、创伤治疗、疼痛管理、发炎管理、整形外科、眼科、妇科和产科。由于羊膜衍生性产品在各个医疗领域的应用不断扩大,以及再生医学对这些独特生物材料的需求不断增加,对羊膜产品的需求不断增加。然而,与生产相关的高成本、对专业设施的需求以及严格的品管措施限制了羊膜产品市场的成长。此外,去细胞技术和临床试验监管核准等技术进步预计将为羊膜产品创造商机。
主要市场统计 | |
---|---|
基准年[2023] | 10.6亿美元 |
预测年份 [2024] | 11.6亿美元 |
预测年份 [2030] | 20.8亿美元 |
复合年增长率(%) | 10.12% |
羊膜型具有优异的癒合能力,应用范围广泛
羊膜是胎盘的最内层,是一种薄的无血管组织,具有独特的癒合特性。在冷冻保存的羊膜 (CAM) 中,这些膜是具有显着治癒潜力的生物支架。脱水羊膜(DAM)是羊膜产品的关键组成部分,利用人类羊膜组织的独特特性来促进癒合和再生。另一方面,与完整的羊膜相比,羊膜悬浮液由于其作为可注射治疗剂的潜在功效和易于使用而成为优选。
应用:羊膜产品在眼科急性伤口治疗的广泛应用
羊膜产品因其能够调节发炎、减轻疼痛和促进组织修復而用于整形外科。在这些情况下,通常会使用羊膜移植物和羊水注射製剂。同时,伤口护理是羊膜产品的另一个重要应用领域,因为它们能够促进伤口快速闭合併最大限度地减少疤痕,包括烧烫伤、手术切口和糖尿病,是治疗足部溃疡等急性伤口的理想选择。羊膜产品因其发炎、抗疤痕和创伤治疗特性而在眼科中用于治疗眼表疾病。角膜溃疡、持续性上皮缺损 (PED)、干眼症 (DES) 和化学烧伤等疾病可以受益于羊膜移植物的使用。
最终使用者:医院增加使用羊膜产品,促进组织再生,加速康復
门诊手术中心 (ASC) 越来越多地采用羊膜产品,因为它们具有独特的特性,例如更快的癒合时间、减少发炎和降低感染风险。羊膜产品有效处理复杂伤口,减少术后併发症,促进患者早日康復。同时,医院中的羊膜产品正在被用作对需要增强组织再生和缩短恢復期的复杂医疗案例的创新治疗解决方案的需求。
区域洞察
由于研究投资的增加和对再生医学解决方案的需求不断增长,羊膜产品的使用正在美洲扩大。公共和私人投资正在帮助推动这一细分市场的创新。在中国、日本和印度等亚太地区国家,消费者对使用羊膜产品的再生医学疗法非常感兴趣。特别是,由于患有糖尿病相关併发症的患者数量不断增加,先进的创伤护理管理解决方案越来越受到关注。此外,政府支持公共和私人研究合作的倡议正在推动羊膜产品的新技术进步。欧盟的 Horizon 2020 计画支持再生医学的创新计划,包括使用羊膜产品的项目。同时,沙乌地阿拉伯和南非等国家对使用羊膜产品的先进伤口护理解决方案的需求不断增加。最近鼓励使用人体组织产品的监管变化也促进了该地区的成长。
FPNV定位矩阵
FPNV定位矩阵对于评估羊膜产品市场至关重要。我们检视与业务策略和产品满意度相关的关键指标,以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估,供应商被分为四个成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市场占有率分析
市场占有率分析是一种综合工具,可以对羊膜产品市场供应商的现状进行深入而详细的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献,以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外,该分析还提供了对该行业竞争特征的宝贵见解,包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。详细程度的提高使供应商能够做出更明智的决策并制定有效的策略,从而在市场上获得竞争优势。
1. 市场渗透率:提供有关主要企业所服务的市场的全面资讯。
2. 市场开拓:我们深入研究利润丰厚的新兴市场,并分析其在成熟细分市场的渗透率。
3. 市场多元化:提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。
4. 竞争评估和情报:对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况和製造能力进行全面评估。
5. 产品开发与创新:提供对未来技术、研发活动和突破性产品开发的见解。
1.羊膜产品市场规模及预测如何?
2.羊膜产品市场预测期间需要考虑投资的产品、细分市场、应用和领域有哪些?
3.羊膜产品市场的技术趋势与法规结构是什么?
4.羊膜产品市场主要厂商的市场占有率是多少?
5. 进入羊膜产品市场的合适型态和策略手段是什么?
[191 Pages Report] The Amniotic Products Market size was estimated at USD 1.06 billion in 2023 and expected to reach USD 1.16 billion in 2024, at a CAGR 10.12% to reach USD 2.08 billion by 2030.
Amniotic products are a category of regenerative medical therapies derived from amniotic tissues sourced from the placenta and amniotic membranes of human donors following a healthy, full-term pregnancy. These products are potentially used in various medical applications such as tissue regeneration, wound healing, pain management, inflammation control, orthopedics, ophthalmology, gynecology, and obstetrics. The expanding applications of amniotic-derived products in various medical fields and an increasing demand for these unique biological materials in regenerative medicine are increasing the need for amniotic products. However, the high cost associated with production, the need for specialized facilities, and stringent quality control measures are restricting the amniotic products market growth. Moreover, technological advancements such as decellularization techniques and the approval of regulatory bodies for clinical trials are expected to create opportunities for amniotic products.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 1.06 billion |
Estimated Year [2024] | USD 1.16 billion |
Forecast Year [2030] | USD 2.08 billion |
CAGR (%) | 10.12% |
Type: Wide applications of amniotic membranes due to its exceptional healing potential
Amniotic membranes are present in the innermost layer of the placenta, comprising a thin, avascular tissue with unique healing properties. In cryopreserved Amniotic Membranes (CAMs), these membranes are biological scaffolds demonstrating exceptional healing potential. Dehydrated Amniotic Membranes (DAMs) are a vital component of amniotic products, which leverage the unique properties of human amniotic tissues to promote healing and regeneration. On the other hand, amniotic suspensions are preferred due to their potential effectiveness as injectable therapeutics and ease of use compared to complete membranes.
Application: Extensive use of amniotic products in ophthalmology to treat acute wounds
Amniotic products are used in orthopedics due to their ability to modulate inflammation, reduce pain, and facilitate tissue repair. Amniotic membrane allografts or injectable amniotic fluid-based products are commonly used in these cases. On the other hand, Wound care is another vital application segment for amniotic products due to their ability to promote rapid wound closure while minimizing scarring, making them ideal for treating acute wounds such as burns, surgical incisions, and diabetic foot ulcers. Amniotic products are used in ophthalmology to treat ocular surface disorders due to their anti-inflammatory, anti-scarring, and wound-healing properties. Conditions such as corneal ulcers, persistent epithelial defects (PEDs), dry eye syndrome (DES), and chemical burns can benefit from using amniotic membrane grafts.
End-User: Increasing use of amniotic products in hospitals for enhanced tissue regeneration and faster recovery
Ambulatory surgery centers (ASCs) are increasingly adopted for amniotic products due to their unique properties, such as faster healing time, reduced inflammation, and lower risk of infection. Amniotic products manage complex wounds effectively, reducing postoperative complications and facilitating quicker patient recovery. On the other hand, amniotic products in hospitals are used as demand for innovative treatment solutions to address complex medical cases requiring enhanced tissue regeneration and faster recovery periods.
Regional Insights
The increasing investment in research and a growing demand for regenerative medicine solutions have expanded the usage of amniotic products in the Americas. Investment from the public and private sectors is helping drive innovation in this market segment. In APAC countries such as China, Japan, and India, there is strong consumer interest in regenerative medicine therapies using amniotic products. In particular, advanced wound care management solutions are gaining traction due to rising cases of diabetes-related complications within their populations. Furthermore, government initiatives supporting research collaboration between public institutions and private enterprises have resulted in new technological advancements that utilize amniotic products. The European Union's Horizon 2020 program supports innovative projects in regenerative medicine, including those using amniotic products. Meanwhile, countries including Saudi Arabia and South Africa represent increasing demand for advanced wound care solutions that incorporate amniotic products. Recent regulatory changes favoring the use of human tissue-based products have also contributed to the growth within this region.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Amniotic Products Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Amniotic Products Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Amniotic Products Market, highlighting leading vendors and their innovative profiles. These include Akorn Operating Company LLC, Applied Biologics LLC, Celularity Inc., Corza Medical, Dallas Regenerative Solutions, Genesis Biologics Inc., Human Regenerative Technologies, LLC, Integra LifeSciences Holdings Corporation, LifeCell International Pvt. Ltd., Merakris Therapeutics Inc., MIMEDX Group, Inc., Next Biosciences Pty Limited, NuVision Biotherapies Ltd., Organogenesis Inc., Orthofix Medical Inc., Skye Biologics Holdings LLC, Smith & Nephew plc, STEMBIOSYS, INC, Stryker Corporation, Surgenex LLC, The Electrospinning Company, Tides Medical, TissueTech, Inc., Ventris Medical LLC, and VIVEX Biologics Inc..
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Amniotic Products Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Amniotic Products Market?
3. What are the technology trends and regulatory frameworks in the Amniotic Products Market?
4. What is the market share of the leading vendors in the Amniotic Products Market?
5. Which modes and strategic moves are suitable for entering the Amniotic Products Market?